BioAtla, Inc. (BCAB)

NASDAQ: BCAB · IEX Real-Time Price · USD
3.52
+0.58 (19.73%)
At close: Jul 5, 2022 4:00 PM
3.51
-0.01 (-0.28%)
Pre-market: Jul 6, 2022 8:46 AM EDT

Stock Price Forecast

According to 12 stock analysts, the average 12-month stock price forecast for BioAtla stock is $31.62, which predicts an increase of 798.3%. The lowest target is $5.05 and the highest is $71.4. On average, analysts rate BioAtla stock as a buy.
Analyst Consensus: Buy
Target Low Average Median High
Price $5.05 $31.62 $25.5 $71.4
Change +43.47% +798.30% +624.43% +1928.4%

Analyst Ratings

The average analyst rating for BioAtla stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jan '22Feb '22Mar '22Apr '22May '22Jun '22
Strong Buy 444444
Buy 666666
Hold 111112
Sell 000000
Strong Sell 000000
Total 111111111112

Financial Forecast

Revenue This Year
3.88M
Increased by 1,450.40%
Revenue Next Year
7.65M
Increased by 97.37%
EPS This Year
-2.84
EPS Next Year
-2.73
Year 201820192020202120222023202420252026
Revenue
10.63M5.20M429.00K250.00K3.88M7.65M17.81M37.56M80.80M
Revenue Growth
-
-51.07%
-91.75%
-41.72%
1,450.40%
97.37%
132.83%
110.88%
115.10%
EPS
-0.52-0.53-3.19-2.76-2.84-2.73-2.63-2.67-2.78
EPS Growth
---------
No. Analysts ----88733

Revenue Forecast

Revenue 20222023202420252026
High 10.5M 15.8M 42.0M 39.4M 84.0M
Avg 3.9M 7.7M 17.8M 37.6M 80.8M
Low n/a n/a 5.6M 36.4M 78.4M

Revenue Growth

Revenue Growth 20222023202420252026
High
73.0%
306.3%
449.0%
121.4%
123.7%
Avg
-36.1%
97.4%
132.8%
110.9%
115.1%
Low - -
-27.0%
104.6%
108.6%

EPS Forecast

EPS 20222023202420252026
High -2.36 -2.05 -2.01 -2.81 -2.89
Avg -2.84 -2.73 -2.63 -2.67 -2.78
Low -3.08 -3.81 -3.03 -2.59 -2.69

EPS Growth

EPS Growth 20222023202420252026
High - - - - -
Avg - - - - -
Low - - - - -